Acquired Epidermodysplasia Verruciformis: A Comprehensive Review and a Proposal for Treatment
Authors:
- Anna ZampettiAZAnna Zampetti
- Federica GiurdanellaFGFederica Giurdanella
- Simona MancoSMSimona Manco
- Dennis LinderDLDennis Linder
- Maria GnarraMGMaria Gnarra
- Giuseppe GuerrieroGGGiuseppe Guerriero
- Claudio FelicianiClaudio Feliciani
- 1 July 2013
- journal article
- case report
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 39 (7) , 974-980
Abstract
Epidermodysplasia verruciformis (EV) is a rare genodermatosis characterized by immunologic abnormalities, disseminated human papilloma virus infection, and early development of skin cancers. Acquired forms have been rarely reported and usually occur with immunosuppression. The therapeutic management of the acquired forms is not standardized, and several therapies have been tried, with variable outcomes. To provide updated clinical and experimental information on the treatment of acquired EV. A Medline literature search was performed for relevant Medical Subject Heading terms, reviewing publications on strategies for management of acquired EV. We also report a case successfully treated using a combination of photodynamic therapy and oral retinoids. Data from the literature show that a standardized approach to this condition is lacking; the combination treatment chosen in our case may be proposed because it led to an excellent clinical outcome and a long-lasting remission.Keywords
This publication has 41 references indexed in Scilit:
- Identification of Defective Fas Function and Variation of the Perforin Gene in an Epidermodysplasia Verruciformis Patient Lacking EVER1 and EVER2 MutationsJournal of Investigative Dermatology, 2008
- Classification of papillomavirusesVirology, 2004
- Epidermodysplasia VerruciformisSouthern Medical Journal, 2003
- Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapyInternational Journal of Dermatology, 2003
- Nonspecific Cell‐Mediated Immunity in Patients with Epidermodysplasia VerruciformisThe Journal of Dermatology, 2003
- Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformisNature Genetics, 2002
- Epidermodysplasia verruciformis: 14 members of a pedigree with an intriguing squamous cell carcinoma transformationInternational Journal of Dermatology, 2002
- Human Papillomavirus Infection and Skin Cancer Risk in Organ Transplant RecipientsJournal of Investigative Dermatology Symposium Proceedings, 2001
- Evidence for a Nonallelic Heterogeneity of Epidermodysplasia Verruciformis with Two Susceptibility Loci Mapped to Chromosome Regions 2p21–p24 and 17q25Journal of Investigative Dermatology, 2000
- Clinical Observations, Virologic Studies, and Treatment Trials in Patients with Epidermodysplasia Verruciformis, a Disease Induced by Specific Human PapillomavirusesJournal of Investigative Dermatology, 1984